Mohamed Omer, MD
Cardiovascular Disease · Leesburg, FLNPI 1366784670
Payments from drug & device makers
Across 113 payments — averaging $124.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$4K
- Medtronic$4K
- Penumbra, Inc.$2K
- Philips North America LLC$2K
- Bard Peripheral Vascular, Inc.$697
- W. L. Gore & Associates, Inc.$490
- plus $884 from 7 others
What the payments were for
- Travel & lodging$8,49860%
- Food & beverage$5,31338%
- Education$2792%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 30 | $4,347 |
| Medtronic(2 entities) | 28 | $3,813 |
| Penumbra, Inc. | 26 | $2,179 |
| Philips North America LLC | 6 | $1,680 |
| Bard Peripheral Vascular, Inc. | 5 | $697 |
| W. L. Gore & Associates, Inc. | 2 | $490 |
| Boston Scientific | 4 | $387 |
| Inari Medical, Inc. | 2 | $223 |
| Edwards Lifesciences | 1 | $119 |
| Abiomed | 3 | $81 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $43 |
| Novo Nordisk | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Indigo System$1,725
- PERCLOSE PROGLIDE$1,686
- HawkOne$1,635
- US Und$1,591
- CoreValve Evolut$1,404
- Omnilink Elite vascular stent system$1,323
- Venclose Maven Catheter$538
- GORE VIABAHN Endoprosthesis$440
- GENERAL VASCULAR ACCESS$233
- CardioMEMS HF System$229
- FLOWTRIEVER CATHETER, S$163
- CT THROMBECTOMY SYSTEM KIT$163
- Supera peripheral stent system$149
- Edwards SAPIEN 3 Transcatheter Heart Valve$119
How this compares
$14,090 in reported general payments places this provider in the 75th percentile of 1,740 cardiovascular disease providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 43 | $53,454 |
| XareltoRivaroxaban | 16 | $18,295 |
| Rosuvastatin Calcium | 63 | $1,069 |
| ClopidogrelClopidogrel Bisulfate | 68 | $741 |
| Metoprolol Succinate | 42 | $689 |
| Atorvastatin Calcium | 41 | $596 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 11 | $468 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 35 | $463 |
| Chlorthalidone | 29 | $349 |
| Metoprolol Tartrate | 18 | $347 |
| Amlodipine Besylate | 53 | $339 |
| Losartan Potassium | 24 | $270 |
| Carvedilol | 29 | $230 |
| Nitroglycerin | 14 | $224 |
| Torsemide | 13 | $219 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Leesburg
- Michael KorenGainesville$31M
- Seth BaumBoca Raton$11.1M
- Alexis GutierrezHialeah$8M
- Eric SpivackAventura$7.1M
- William OneillNaples$4.6M
- Rafik AbadierInverness$4.4M
- Alvaro MurciaPembroke Pines$4M
- David HotchkissPort Charlotte$4M
- Ferris GeorgeSt Augustine$3.8M
- Duccio BaldariWellington$3.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.